HIGH FIBROBLAST GROWTH FACTOR 23 LEVELS INCREASE RISK OF SARS-COV-2 INFECTION AND MORTALITY IN END-STAGE CHRONIC KIDNEY DISEASE ON HEMODIALYSIS: A 3-YEAR FOLLOW-UP PROSPECTIVE COHORT